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TRIP8b (tetratricopeptide repeat–containing Rab8b-interacting protein) is the neuronal regulatory subunit of HCN channels, a
family of voltage-dependent cation channels also modulated by direct cAMP binding. TRIP8b interacts with the C-terminal
region of HCN channels and controls both channel trafficking and gating. The association of HCN channels with TRIP8b is
required for the correct expression and subcellular targeting of the channel protein in vivo. TRIP8b controls HCN gating by
interacting with the cyclic nucleotide-binding domain (CNBD) and competing for cAMP binding. Detailed structural knowledge
of the complex between TRIP8b and CNBD was used as a starting point to engineer a mutant channel, whose gating is
controlled by cAMP, but not by TRIP8b, while leaving TRIP8b-dependent regulation of channel trafficking unaltered. We
found two-point mutations (N/A and C/D) in the loop connecting the CNBD to the C-linker (N-bundle loop) that, when
combined, strongly reduce the binding of TRIP8b to CNBD, leaving cAMP affinity unaltered both in isolated CNBD and in the
full-length protein. Proof-of-principle experiments performed in cultured cortical neurons confirm that the mutant channel
provides a genetic tool for dissecting the two effects of TRIP8b (gating versus trafficking). This will allow the study of the
functional role of the TRIP8b antagonism of cAMP binding, a thus far poorly investigated aspect of HCN physiology in
neurons.
Introduction
In cortical and hippocampal pyramidal neurons, hyperpolarization-
activated and cyclic nucleotide–gated (HCN) 1 subunits, the
predominant HCN isoform, are selectively targeted to
the distal regions of apical dendrites (Santoro et al., 1997;
Magee, 1998; Lo¨rincz et al., 2002). At these sites, the
hyperpolarization-activated cation current (Ih) current gener-
ated by HCN channels controls dendritic excitability by filtering
the integration of excitatory inputs (Magee, 1999; Williams and
Stuart, 2000; Tsay et al., 2007; George et al., 2009). Aberrant
regulation of HCN1 expression causes enhanced dendritic ex-
citability, which, in turn, is associated with the development of
temporal lobe epilepsy (Dube´ et al., 2009; Shah et al., 2013).
Therefore, both localization and function of HCN channels in the
brain must be strictly and finely controlled.
To this end, HCN channels possess a regulatory subunit,
TRIP8b (tetratricopeptide repeat–containing Rab8b-interacting
protein), which is specifically expressed in the brain. TRIP8b
tightly colocalizes with HCN1 in the distal dendrites of cortical
and hippocampal pyramidal neurons (Santoro et al., 2004).
TRIP8b interacts with two different regions of the HCN C
terminus: the C-terminal tripeptide SNL, a conserved sequence
in HCN1, HCN2, and HCN4; and the cyclic nucleotide–binding
domain (CNBD), also highly conserved among the three iso-
forms. Binding to the C-terminal SNL peptide is mediated by the
tetratricopeptide repeat (TPR) domain, which is critical in con-
trolling trafficking of HCN channels both in vitro and in vivo
(Santoro et al., 2004, 2009, 2011; Piskorowski et al., 2011; Lewis
et al., 2009). The precise channel distribution in the dendrites of
both cortical and hippocampal neurons exactly matches that of
TRIP8b and is lost in the TRIP8b-knockoutmouse (Santoro et al.,
2004, 2009; Piskorowski et al., 2011; Lewis et al., 2011), high-
lighting the crucial role of TRIP8b in the maintenance of ap-
propriate HCN expression levels in these neurons.
A second interaction occurs between the HCN CNBD and the
“core” region of TRIP8b, a central portion of ∼40 amino acids
upstream of the TPR domain (Saponaro et al., 2018). TRIP8b, by
competing with cAMP for binding to the CNBD, negatively shifts
the voltage-dependent gating of HCN channels (Saponaro et al.,
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2018). This antagonistic effect was previously described as a mix
of direct competition and allosteric inhibition (Hu et al., 2013).
This postulated mechanism of interaction has been now sup-
ported by a structural model of the TRIP8b–HCN complex
showing that TRIP8b interacts with the CNBD in two ways: (1)
by directly competing with cAMP for binding to key residues on
the C-helix; and (2) by binding to residues on a N-terminal loop
connecting helix E9 to helix A, called N-bundle loop, that allo-
sterically controls cAMP affinity (Saponaro et al., 2018).
Interestingly, the voltage dependency of HCN current gradu-
ally shifts to the left along the dendritic axis of pyramidal neurons
(Magee, 1998, 1999). This gradient matches a similar gradient of
TRIP8b expression in the same neurons and points to the fact that
the same auxiliary subunit that controls channel distribution may
also allow a fine tuning of its electrical properties.
In this respect, it would be useful to have an experimental
tool able to dissect the two effects of TRIP8b on the channel in
order to test the role of TRIP8b in modulating cAMP binding
without altering expression and localization of the channel in
the neuron. Identifying such mutations would allow to more
effectively explore the role of TRIP8b in limiting the cAMP re-
sponse of HCN channels in vivo.
Amutagenesis study on TRIP8b suggested that the trafficking
effect exerted by the regulatory protein on HCN channels is
mediated by its association with trafficking factors, whose
binding sites are located in different regions of TRIP8b, in-
cluding the two binding sites for HCN channels (TRIP8bnano
sequence and TRP domain; Santoro et al., 2011). Therefore, an
intact TRIP8b is necessary for the proper functioning of its
trafficking effect. In order not to perturb the TRIP8b trafficking
system, we thus decided to focus our attention onHCN channels.
Furthermore, the CNBD region of HCN channels is well char-
acterized both in term of its structure and function (Saponaro
et al., 2014, 2018; Puljung et al., 2014; Zhou and Siegelbaum,
2007; Porro et al., 2019; Zagotta et al., 2003; Lolicato et al.,
2011; Xu et al., 2010; Akimoto et al., 2014; Wainger et al., 2001)
and thus represents a robust model system in which to search
for the desired mutation.
To screen for such mutations, given the role of the CNBD
C-helix in directly contacting cAMP, we focused our efforts on
the N-bundle loop and proceeded to test candidate mutations for
cAMP binding activity.
Here, we describe how we have identified a site-specific
double mutation in the N-terminal bundle loop of HCN, which
impairs TRIP8b binding to the CNBD but leaves the affinity for
cAMP unaltered. Since the trafficking effect of TRIP8b on HCN
ismaintained, the mutation constitutes a valuable tool for future
dissection of the multiple TRIP8b actions and for a characteri-
zation of the cAMP–TRIP8b regulatory system in vivo.
Materials and methods
Constructs
The cDNA encoding residues 235–275 (TRIP8bnano) of murine
TRIP8b (splice variant 1a-4) was previously cloned into pET-52b
(EMD Millipore) bacterial expression vector (Saponaro et al.,
2018). The cDNA encoding residues 521–672 of human HCN2
CNBD was previously cloned into a modified pET-24 (Saponaro
et al., 2014) bacterial expression vector. The cDNA encoding full-
length human HCN1 channel and mouse TRIP8b (1a-4) were
cloned into the pcDNA 3.1 (Clontech Laboratories) mammalian
expression vector. The cDNA encoding full-length mouse HCN2
was cloned in pCI (Promega) mammalian expression vector.
Mutations were generated by site-directed mutagenesis (Quik-
Change site-directed mutagenesis kit; Agilent Technologies) and
confirmed by sequencing.
Preparation of proteins
HCN2 CNBD WT and mutant proteins and TRIP8bnano WT and
mutant peptides were produced and purified following the
procedure previously described (Saponaro et al., 2014). Fig. S1
shows size-exclusion chromatography (SEC) profiles of HCN2
CNBD and TRIP8bnano WT and mutants performed as a final step
of their purification procedure. SEC profiles were used to assess
protein stability.
Isothermal titration calorimetry (ITC)
Measurements were performed at 25°C using aMicroCal VP-ITC
microcalorimeter (Malvern Panalytical, ITC) following the
procedure previously described (Saponaro et al., 2014, 2017;
Saponaro, 2018).
Electrophysiology of HEK 293T cells
Cells were cultured and transfected following the procedure
previously described (Saponaro et al., 2018; Porro et al., 2019).
Whole-cell currents of HCN1 and HCN2 channels were recorded
at room temperature 24 h after transfection either with a Dagan
3900A (Dagan Corporation) amplifier, or with an ePatch am-
plifier (Elements srl). For what concerns the data acquired with
the Dagan 3900A amplifier, they were digitized with an Axon
Digidata 1322A (Molecular Devices) converter. Voltage-clamp
protocols are detailed in Saponaro et al. (2018). All data were
analyzed offline with Axon pClamp 10.7 and Origin 16 (OriginLab
Corp.) as detailed in Saponaro et al. (2018) and Porro et al. (2019).
Neuronal cell cultures and transfection
Primary cultures of cortical neurons were obtained from neo-
natal rats and cultured as previously reported (Binda et al., 2018;
Bonzanni et al., 2018). Cortical neurons from human induced
pluripotent stem cells (hiPSCs) were commercially available (iCell
Neurons; Cellular Dynamic International) and cultured following
manufacturer’s instructions. Both types of neurons were tran-
siently transfected using jetPRIME transfection reagent (Polyplus
transfection; Euroclone) following manufacturer’s instructions.
pcDNA3.1 vector containing 1 µg cDNA of either WT or mu-
tant HCN1 channels was cotransfected with a plasmid containing
cDNA of GFP (0.3 µg) for transient expression. For coexpression
with TRIP8b (1a-4), neurons were transiently transfected with
1 µg cDNA of either WT or mutant HCN1 channels, 1 µg cDNA of
TRIP8b (1a-4) WT, and 0.3 µg cDNA of GFP.
Electrophysiology of neuronal cell cultures
Whole-cell patch-clamp experiments were performed at room
temperature 48 h after transfection (Bonzanni et al., 2018).
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GFP-positive neurons were selected for the recording. The extra-
cellular solution was composed as follows (in mM): 140 NaCl, 5.4
KCl, 1.8 CaCl2, 1 MgCl2, 5.5 D-glucose, and 5 HEPES-NaOH, pH
7.4. During whole-cell recording, the perfusing solution was
switched to a high-K+ solution containing (in mM) 110 NaCl, 0.5
MgCl2, 1.8 CaCl2, 5 HEPES-NaOH, 30 KCl, 1 BaCl2, 2 MnCl2, and
0.1 NiCl, pH 7.4. The intracellular-like solution contained (in
mM) 130 KCl, 10 NaCl, 1 EGTA-KOH, 0.5 MgCl2, 2 ATP (Na2-salt),
5 creatine phosphate, 0.1 GTP (Na2-salt), and 5 HEPES-KOH, pH
7.2. From a holding potential of −30 mV, hyperpolarizing steps
in the range of −20 to −120 mV followed by a fully activating step
at −120 mV were applied to measure activation curves in stan-
dard two-step protocols. Single activation curves were fitted to
the Boltzmann equation y = 1/{1 + exp[(V − V1/2)/s]}, where V is
voltage, V1/2 is half-maximum activation potential, and s is the
inverse slope factor, to yield V1/2 and s values, which were then
averaged (DiFrancesco, 1999). The current–voltage relationship
curves were obtained normalizing the current amplitude at each
step tested by the cell capacitance and plotting the current
density obtained versus the voltage test pulse. Activation and
deactivation time constants (τ) were obtained by fitting a single
exponential function, I = I0exp(−t/τ), to current traces obtained
with the activation protocol described above. Deactivation time
constants were obtained by fitting tail currents collected at
−40 mV after a fully activation pulse at −130 mV.
Statistical analysis
Statistical significance was assessed with one-way ANOVA,
followed by post-hoc Tukey or Fisher tests where applicable.
The α level was set to 0.05 for all statistical analysis. All analyses
were performed using Origin 16 (OriginLab Corp.).
Online supplemental material
Fig. S1 shows representative SEC profiles of His6-MBP–tagged
human HCN2 CNBD and Strep-tagged TRIP8bnano WT and mu-
tants performed to assess protein stability. These proteins were
used for ITC assays related to Figs. 2 and 4 and Table 1. Fig. S2
shows the structure of human HCN2 CNBD and emphasizes the
N-bundle loop, the structural element where the double muta-
tion NA/DC is located. Fig. S3 shows the electrophysiological
assay performed to test the cAMP sensitivity of mouse HCN2
NA/DC mutant channels.
Results
Identification of a mutation that impairs TRIP8b binding to
CNBD but not cAMP
The interaction of TRIP8b with the HCN channel’s CNBD has
been characterized at atomic level by an NMR-based model
structure of the complex formed by human HCN2 CNBD and
TRIP8bnano, a 40–amino acid–long peptide that constitutes the
minimal binding unit of TRIP8b to the CNBD (Fig. 1 A). The
complex is formed mainly by electrostatic interactions, with
TRIP8bnano contributing negative and CNBD positive charges.
TRIP8bnano establishes salt bridges in two sites of the CNBD
C-helix: (1) residues K666, K665, and R662 (site I); and (2) res-
idue R650 (site II). TRIP8bnano further interacts with the CNBD
in a third point, at the level of the N-bundle loop, forming a
hydrogen bond with N547 (site III).
We have previously validated the model of the CNBD–
TRIP8bnano complex by showing that reversing (K666E, K665E,
and R662E) or introducing (N547D) a charge in these positions
strongly reduces the binding affinity for TRIP8nano, presumably
due to electrostatic repulsion with the negatively charged resi-
dues of TRIP8bnano (Saponaro et al., 2018).
In search for a mutation that disrupts TRIP8b, but not cAMP,
binding, we first checked the affinity for cAMP in the above
mutants. Since HCN2 is very sensitive to cAMP (Lolicato et al.,
2011; Wainger et al., 2001), we decided to use this isoform to
screen for mutations that did not perturb cAMP binding and
efficacy.
Of the three mutants at site I, we picked K666E, but not
K665E and R662E. R662E was discarded because R662 directly
contacts cAMP in the crystal structure of CNBD (Zagotta et al.,
2003; Lolicato et al., 2011; Fig. 1 B). K665E was not tested because
it was previously shown that alanine substitution of the corre-
sponding K638 in mHCN2 channels already alters cAMP sensi-
tivity (Zhou and Siegelbaum, 2007).
Affinity of K666E for cAMP was evaluated by ITC. Fig. 2, A
and B show heat exchanges obtained by injecting cAMP (titrant)
into the chamber containing either WT or K666E CNBD (ti-
trands), respectively. The binding curve was obtained by inte-
grating the peaks (upper panels) and plotting the values as a
function of the molar ratio between titrant and titrand (lower
panels). By fitting a single binding site model to the data (red
solid line), we calculated the average Kd values (n = 3 repetitions)
reported in Table 1. The mutant shows a threefold decreased
affinity for cAMP compared with the WT (K666E = 6.3 ± 0.3 µM;
WT = 1.9 ± 0.1 µM). The reduction in cAMP affinity is moderate
but significant (Table 1).
Next, we tested R650E, which controls TRIP8bnano binding at
site II. This residue does not directly contact the cAMP binding
pocket and was therefore considered a promising candidate for
our purpose. ITC analysis (Fig. 2 C) shows an even more mod-
erate, though still significant, change in cAMP affinity with re-
spect to the control CNBD. The mean Kd value is 1.9 ± 0.1 µM for
WT and 4 ± 0.1 µM for the mutant (Table 1).
In our experience, moderate changes in the Kd, like the ones
we measured by ITC for K666E and R650E mutants, may have
a likewise modest but significant effect when tested in
electrophysiology.
As a precaution, we therefore decided to test whether R650E
mutation, which caused the most moderate reduction of cAMP
affinity in the isolated CNBD (Fig. 2 C and Table 1), could sig-
nificantly affect cAMP sensitivity also in the full-length channel.
Mouse HCN2 R632E (corresponding to R650E) was transiently
expressed in HEK 293T cells and its currents recorded by patch
clamp in the absence and in the presence of 5 µM cAMP in the
patch pipette. Fig. 3 A shows a comparison of representative
currents elicited by WT and mutant channels, respectively.
Fig. 3 B shows the mean activation curves of the two channels
obtained from the analysis of currents in A and other cells (n ≥
10). Activation curves were obtained from tail currents recorded
at −40 mV, normalized for the cell capacitance and plotted as a
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function of the preconditioning voltage. Fitting data to a Boltz-
mann equation (solid lines of Fig. 3 B; see Materials andmethods
for the equation) yielded the half-activation potentials (V1/2;
Fig. 3 C). The mutant channel shows no difference in V1/2 in
control solution (WT = −96.1 ± 0.5 mV; mutant = −96.4 ± 0.4 mV)
but appears slightly less responsive to cAMP than the WT
channel (WT = −84 ± 0.4 mV; mutant = −86.9 ± 0.4 mV). On
average, the shift induced by 5 µM cAMP on V1/2 is 12.1 ± 0.6 mV
for the WT and 9.5 ± 0.6 mV for the mutant channel. This effect
was considered nonnegligible. Given the fact that the reduction
in cAMP binding/response due to R650E (R632E inmHCN2) was
confirmed to be moderate but significant in two different ex-
perimental conditions (Fig. 3 and Table 1), we decided to look for
other possible mutants in site III.
The crucial residue of site III, N547, is in the loop connecting
helix E9 of the C-linker to helix A at the N-terminus of the CNBD
(N-bundle loop; Fig. 1 A). The loop is a crucial regulatory point of
the channel, as it mechanically connects the CNBD to the
C-linker. Upon cAMP binding to the CNBD, the loop forms a new
helix (F9) that moves upward together with helices E9 and A, the
so-called N-terminal helical bundle, thus propagating cAMP
signal from the CNBD to the rest of the protein via the C-linker
(Saponaro et al., 2014; Lee and MacKinnon, 2017; Li et al., 2017).
Our previous finding that mutation N547D disrupts not only
TRIP8nano but also cAMP binding (Saponaro et al., 2018) un-
derscored a previously unaddressed role of the N-bundle loop in
allosterically modulating cAMP binding to the CNBD.
As the N547D mutation did not satisfy our criteria for iso-
lating TRIP8b binding from cAMP binding activity, we consid-
ered alternative mutations. Interestingly, the closely related
CNG channels, which bind to cAMP like HCN channels but do
not bind to TRIP8b (Santoro et al., 2011), carry an aspartate in-
stead of asparagine at the position corresponding to N547, just
like the N547D mutant. The aspartate in CNG is however fol-
lowed by a second substitution within an otherwise highly
conserved sequence, namely a cysteine instead of alanine (Fig.
S2). To fully mimic the CNG channel sequence, we thus intro-
duced a double point mutation in our HCN CNBD construct.
Binding assays performed by ITC show that the HCN CNBD
N547D/A548C mutant (hereafter NA/DC) displays a 6-fold de-
crease in the affinity for TRIP8bnano (compare Fig. 4 A to Fig. 4 C;
Table 1). In contrast, the affinity for cAMP of the double muta-
tion remains essentially unaltered (Fig. 2 D and Table 1), as ex-
pected from the homology with CNG channels. Importantly, the
decrease of TRIP8bnano binding activity due to the NA/DC mu-
tation in the CNBD (Fig. 4 C and Table 1) was largely rescued by
pairing CNBD NA/DC mutant with the D252N point mutation in
TRIP8bnano (Fig. 4 D and Table 1). The results of this swap ex-
periment provide further demonstration that the NA/DC double
mutant is appropriately folded and strongly support an inter-
action between residues in the CNBD N-bundle loop and the
bend region between helix N and helix C of TRIP8bnano, as
predicted by our model (Fig. 1 A). It is worth noting that
TRIP8bnano D252Nmutant did not affect binding to CNBD (Fig. 4 B
and Table 1), presumably because the added asparagine residue
can develop hydrophilic contacts with N547 of CNBD.
Having demonstrated that the NA/DC double mutation af-
fects TRIP8b, but not cAMP, binding to the isolated HCN2 CNBD,
for completeness, we showed that cAMP response is unaltered
also in the full-length HCN2 channel upon introduction of the
NA/DC mutation (Fig. S2 and Fig. S3).
NA/DC mutation in the full-length channel
Considering these findings, we next tested whether the NA/DC
double mutation may also be able to affect TRIP8b binding (but
not cAMP binding) in the context of a full-length channel.
Figure 1. The HCN CNBD–TRIP8bnano complex. (A) Ribbon representation of the NMR-based model structure of the complex between human HCN2 CNBD
(light gray) and TRIP8bnano (gold). The structural elements of both proteins involved in the binding are labeled as follows: for the CNBD, E9-helix (αE9) and
A-helix (αA), which form, together with their inter-helical loop, the N-terminal helical bundle; C-helix (αC); for TRIP8bnano, helix N (N) and helix C (C). Negatively
charged residues of TRIP8bnano and positively charged residues of CNBD (αC), which are involved in the electrostatic interaction, are shown as sticks, labeled
and colored in red and blue, respectively. D252 of TRIP8bnano and N547 of the N-bundle loop and are shown as sticks and labeled. (B) Ribbon representation of
human HCN2 CNBD (dark gray) bound to cAMP (PDB accession no. 3U10). cAMP (green stick) is shown within its binding pocket composed by the β-roll and
the distal region of α helix C, which acts as a lid and closes cAMP within the β-roll. Residue R662 (yellow stick) of α helix C, which contacts cAMP, is shown. The
structural elements of CNBD are labeled.
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The motivation for searching for the NA/DC mutation is to
use it in physiological contexts in vivo as a genetic tool to dissect
the two effects of TRIP8b (gating versus trafficking) on HCN
channels. Therefore, we focused our attention on HCN1, given
the well-characterized interaction between this HCN isoform
and TRIP8b in neurons. We thus introduced the mutation in
HCN1 channels, the predominant HCN isoform in cortical and
hippocampal pyramidal neurons, whose gating and trafficking
are controlled by TRIP8b both in vitro and in vivo (Santoro et al.,
2009; Piskorowski et al., 2011; Lewis et al., 2009, 2011). More-
over, we coexpressed HCN1 channels with TRIP8b splice variant
1a-4, as this is the predominant isoform in the forebrain and is
crucial for the proper localization of HCN1 in pyramidal neurons
(Santoro et al., 2009; Piskorowski et al., 2011).
The mutation in HCN1 channels, by preventing TRIP8b
binding to CNBD, may result in a selective inhibition of the
gating regulation without affecting the trafficking regulation.
Indeed, it is worth remembering that TRIP8b (1a-4) exerts its
effect on channel trafficking mainly by means of the TPR do-
main, which is not involved in the binding to CNBD (Santoro
et al., 2011).
We therefore recorded currents from HEK 293T cells tran-
siently transfected with HCN1 alone or together with TRIP8b
(1a-4; Fig. 5 A). Fig. 5 B shows the activation curves obtained
from tail currents recorded at −40 mV (see arrow in Fig. 5 A),
normalized for the cell capacitance and plotted as a function of
the preconditioning voltage. The half-activation potential (V1/2),
yielded from the fitting of the data to the Boltzmann equation
(solid and dashed lines of Fig. 5 B; see Materials and methods for
equation), is plotted in Fig. 4 C. Fig. 5 D shows maximal current
density values calculated at the saturating voltage of −120 mV
(see arrowhead in Fig. 5 B).
Because of its higher affinity for cAMP compared with the
other HCN isoforms, the HCN1 isoform shows virtually a fully
rightward shifted activation curve due to the endogenous cAMP
levels present in HEK 293T cells (Saponaro et al., 2018). When
Figure 2. In vitro analysis of CNBD–cAMP
interaction. Examples of binding of cAMP to
His6-MBP-tagged human HCN2 CNBD WT (A)
and mutants (B–D) measured by ITC. Top: Heat
changes (μcal/s) during successive injections of
8 µl of the corresponding cAMP (200 µM) into
the chamber containing CNBD (20 µM). Bottom:
Binding curve obtained from data displayed in
the upper panel. The peaks were integrated,
normalized to cAMP concentration, and plotted
against the molar ratio (cAMP/CNBD). Solid red
line represents a nonlinear least-squares fit to a
single-site binding model (see Materials and
methods).
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TRIP8b (1a-4) is cotransfected with HCN1, the V1/2 of the channel
is shifted significantly to more hyperpolarized potentials (HCN1
WT = −72.7 ± 0.4 mV; HCN1 WT + TRIP8b (1a-4) = −78.2 ± 0.5
mV; Fig. 5, B and C). This reflects the fact that TRIP8b prevents
cAMP binding to the channel. This negative shift in the activa-
tion curve closely matches the shift recorded with the HCN1
R549E cAMP-insensitive mutant, which essentially prevents
cAMP binding (Chen et al., 2001; Saponaro et al., 2018),
suggesting that TRIP8b fully antagonizes the interaction of
endogenous cAMP with the channel.
It is worth noting that whole-cell configurationwas preferred
over inside-out because of the known tendency of TRIP8b to
dissociate fromHCN1 upon patch excision (Santoro et al., 2009).
It is therefore possible that the control condition does not strictly
represent the currents in the complete absence cAMP.
As noted in previous studies (Lewis et al., 2009; Santoro
et al., 2009), cotransfection of TRIP8b (1a-4) has also a second
effect on HCN1 channel function, namely an ∼2.5-fold increase
in maximal current density (Fig. 5, B and D).
We thus introduced the NA/DC double mutation in the
background of the full-length human HCN1 channel (N478D/
A479C). Consistent with its effect on the isolated CNBD frag-
ment, the doublemutant had a rightward shifted V1/2 identical to
the WT HCN1 channel (HCN1 NA/DC = −72.6 ± 0.6 mV; Fig. 5, B
and C). This confirms an intact response of the mutant to en-
dogenous cAMP and shows, quite strikingly, that cotransfection
with TRIP8b (1a-4) was completely ineffective in preventing the
facilitatory effect of cAMP on channel activation (HCN1 NA/DC +
TRIP8b (1a-4) = −73.2 ± 0.4 mV; Fig. 5, B and C). It is worth
noting that TRIP8b decreases the kinetics of channel opening,
while increasing the kinetics of channel closing (Santoro et al.,
2009). As expected, the presence of TRIP8b significantly re-
duced the time constants of HCN1 current activation, while ac-
celerating the time constant of deactivation (Fig. 5 E and
Table 2). The NA/DC double mutation, by impairing the TRIP8b-
Table 1. cAMP and TRIP8bnano binding to CNBD
Titrant CNBD
(titrad)
Kd ± SEM
(μM)
P value (compared
to WT)
n
cAMP WT 1.9 ± 0.1 — 3
R650E 4 ± 0.1 3.2E-04 3
K665E 6.3 ± 0.3 1.2E-06 3
N547D/A548C 1.8 ± 0.1 0.98 3
TRIP8bnano WT WT 1.3 ± 0.1 — 3
TRIP8bnano D252N WT 3.5 ± 0.5 0.1 3
TRIP8bnano WT N547D/A548C 9.3 ± 0.9 4.8E-5 3
TRIP8bnano D252N N547D/A548C 3.6 ± 0.6 0.09 3
ITC measurements of cAMP and Strep-tagged TRIP8bnano (WT and mutant)
binding to His6-MBP–tagged human HCN2 CNBD (WT and mutants). Data are
reported as mean ± SEM. Statistical analysis performed with one-way
ANOVA, followed by post-hoc Tukey test.
Figure 3. cAMP sensitivity of HCN2 R632E
channel. (A) Representative whole-cell current
traces of mouse HCN2 WT (top) and R632E
mutant (bottom) recorded in HEK 293T cells
transiently expressing the channels with control
solution (left) or with 5 µM cAMP (right) in the
patch pipette. Arrows indicate the currents se-
lected for analysis in B. (B) Normalized mean
activation curves of HCN2WT in control solution
(blue filled circle) and cAMP (blue open circle)
and HCN2 R632E in control solution (green filled
circle) and cAMP (green open circle) obtained
from tail currents collected at −40 mV (see ar-
rows in A). Lines show data fit to a Boltzmann
function (see Materials and methods), from
which we derived the half-activation potentials
(V1/2) plotted in C. (C) Mean half-activation po-
tential (V1/2) of HCN2 WT in control solution
(blue filled circle) = −96.3 ± 0.4 mV; HCN2 WT
with cAMP (blue open circle) = −83.7 ± 0.3 mV;
HCN2 R632E in control solution (green filled
circle) = −96.4 ± 0.3 mV; HCN2 R632E with
cAMP (green open circle) = −86.7 ± 0.3 mV.
Data are plotted as dots and the line represents
the mean value ± SEM. The number of cells was
≥10. Statistical analysis performed with one-way
ANOVA, followed by post-hoc Tukey test (P
values are denoted within the scatterplot graph).
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dependent regulation of HCN1 gating, impaired also its ability to
modulate HCN1 kinetics (Fig. 5 E and Table 2).
At the same time, TRIP8b still exerted its normal positive
effect on channel surface expression, as reflected by the increase
in maximal current density of the mutant channel, which is
comparable to WT (Fig. 5, B and D).
In conclusion, the double mutation NA/DC in the HCN CNBD
is enough to prevent the effect of TRIP8b on cAMP, while having
no impact on the role of TRIP8b to promote channel expression
and trafficking. Based on these results, we reckoned the double
mutation may be employed as a genetic tool for dissecting
TRIP8b actions (gating versus trafficking) on HCN channels.
NA/DC mutation in the physiological context of neurons
We next tested the effect of the NA/DC mutant in the more
physiological context of neurons. As proof of principle, we first
employed primary cultures of cortical neurons from neonatal
rats. These cells were transiently transfected with HCN1 (WT or
NA/DC mutant) alone, or together with TRIP8b (1a-4).
Based on the results in HEK 293T cells, we expected the NA/
DC mutation to prevent TRIP8b-induced effects on gating, but
not on trafficking. Fig. 6 A shows representative currents re-
corded from cells transfected with HCN1 WT or NA/DC, with or
without TRIP8b (1a-4). As expected, regardless of the double
mutation, TRIP8b (1a-4) exerted its normal positive effect on
channel surface expression, as it increased the current density
roughly to the same extent in both WT and NA/DC (∼2.3- and
2.2-fold increase, respectively; Fig. 6 B and Table 3).
Co-transfection with TRIP8b significantly left shifted the
HCN1 WT activation curve (V1/2 = −81.9 ± 1.4 mV for HCN1 WT;
V1/2= −88.6 ± 1.1 mV HCN1 WT + TRIP8b (1a-4); Fig. 6, C and D),
indicating that TRIP8b prevents cAMP binding to the channel
also in the native context of cortical neurons, and that basal
cAMP levels in these cells are sufficiently high to fully activate
the channel in the absence of TRIP8b.
Consistent with the effect shown in HEK 293T cells, the NA/
DC mutant had a rightward shifted V1/2 identical to the WT
HCN1 channel (V1/2 = −82.4 ± 1 mV; Fig. 6, C and D). This
Figure 4. In vitro analysis of CNBD–
TRIP8bnano interaction. (A–D) Examples of
binding of Strep-tagged TRIP8bnano (WT and
mutants) to His6-MBP-tagged human HCN2
CNBD (WT and mutants) measured by ITC. Top:
Heat changes (µcal/s) during successive in-
jections of 8 µl of the corresponding TRIP8bnano
(200 µM) into the chamber containing CNBD (20
µM). Bottom: Binding curve obtained from data
displayed in the top panel. The peaks were in-
tegrated, normalized to TRIP8bnano concen-
tration, and plotted against the molar ratio
(TRIP8bnano/CNBD). Solid red line represents a
nonlinear least-squares fit to a single-site binding
model (see Materials and methods).
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confirms an intact response of the mutant to endogenous cAMP.
Strikingly, TRIP8b (1a-4) was completely ineffective in pre-
venting the facilitatory effect of cAMP on the activation of
mutant channel (V1/2 = −82.2 ± 1.2 mV; Fig. 6, C and D). Con-
sidering the current density at −120 mV of mock-transfected
neurons (−10.6 ± 1.8 pA/pF, n = 25) and its comparison with
the HCN1-transfected ones (see Table 3), we can conclude
that the contribution of endogenous HCN, presumably HCN1
(Battefeld et al., 2012), and TRIP8b, is truly negligible.
To maintain the complexity of the neuronal background and,
at the same time, analyze the behavior of the double HCN1
mutant in a human system, we turned our attention to cortical
neurons derived from hiPSCs.
Despite the fact that the measured currents were smaller in
this system (Fig. 7, A and B), the coexpression of TRIP8b (1a-4) with
HCN1 channels induced an increase of ∼2.5-fold in the current
density of bothWT andNA/DCmutant (Fig. 7, A and B; and Table 4),
the same extent of the increase measured in rat cortical neurons.
Once again, the presence of TRIP8b induced a significant
negative shift in the activation curve of HCN1 WT compared
with the mutant channel (Fig. 7 C; V1/2 = −85.1 ± 1.9 mV for WT;
V1/2 = −79.9 ± 1.7 mV for the mutant; P = 0.034). It is worth noting
that when HCN1 channels (both WT and mutant) are expressed
alone we could not carefully measure activation curves because of
the low current density. On the contrary, TRIP8b, by increasing
channel surface expression, allowed us to properly analyze acti-
vation curves (Fig. 7 C). Nonetheless, considering the data gathered
in the other cellular systems and that, contrary to HCN1 WT, the
activation curve of NA/DC is insensitive to TRIP8b (Fig. 7 C), we
assume that human derived-cortical neurons HCN1 WT and NA/
DC mutant possess the same sensitivity for endogenous cAMP.
Taken together, these findings indicate that NA/DC mutation
exerts its inhibitory effect on the TRIP8b-dependent control of
HCN channel gating, while leaving unaffected the regulation of
trafficking and expression, even in the more physiological
context of cultured cortical neurons.
Figure 5. The NA/DC double mutation in HCN1 prevents TRIP8b regulation of channel function. (A) Representative whole-cell current traces of human
HCN1 WT (top) and N478D/A479C (NA/DC) mutant (bottom) recorded in HEK 293T cells transiently expressing the channels alone (left) or with TRIP8b (1a-4;
right) and analyzed as described in Materials and methods. Arrows indicate the current selected for analysis in B. (B)Mean activation curves of HCN1WT (black
filled circle), HCN1 WT + TRIP8b (1a-4; black open circle), HCN1 NA/DC (red filled circle), and HCN1 NA/DC + TRIP8b (1a-4; red open circle) channels obtained
from tail currents collected at −40 mV (see arrows in A). The currents were normalized for the cell capacitance and plotted (changed in sign) as a function of
test voltages. Solid and dashed lines indicate the half-activation potential (V1/2) value, while arrowheads indicate the current density value at saturation,
plotted respectively in C and D. (C)Mean half-activation potential (V1/2) of HCN1WT (black filled circle) = −72.7 ± 0.4 mV; HCN1WT + TRIP8b (1a-4; black open
circle) = −78.2 ± 0.5 mV; HCN1 NA/DC (red filled circle) = −72.6 ± 0.6 mV; and HCN1 NA/DC + TRIP8b (1a-4; red open circle) = −73.2 ± 0.4 mV. P values are
denoted within the scatter plot graph. (D)Mean maximal tail current density of HCN1 WT (black filled bar) = 10.1 ± 2.7 pA/pF; HCN1 WT + TRIP8b (1a-4; black
open bar) = 23 ± 8 pA/pF; HCN1 NA/DC (red filled bar) = 9.6 ± 4 pA/pF; and HCN1 NA/DC + TRIP8b (1a-4; red open bar) = 23.8 ± 4.5 pA/pF. P values are denoted
within the column bar graph. (E) Mean activation and deactivation time constants (before and after the x-axis break, respectively) of HCN1 WT (black filled
circle), HCN1 WT + TRIP8b (1a-4; black open circle), HCN1 NA/DC (red filled circle), and HCN1 NA/DC + TRIP8b (1a-4; red open circle). Time constant of
activation and deactivation were calculated, as described in Materials and methods. All values and exact P values are reported in Table 2. Data are plotted as a
dot and the line represents the mean value ± SEM. n = 8 cells. Statistical analysis performed with one-way ANOVA, followed by post-hoc Tukey test.
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As in the case of rat cortical neurons, we could not ex-
clude the presence of endogenous HCN1 and TRIP8b proteins
in hiPSC-derived neurons. Nonetheless, considering that
HCN1 current recorded from transfected neurons was about
three time higher than the current recorded from mock-
transfected cells (mean current density at −120 mV of
HCN1 WT −27.2 ± 7.7 pA/pF; mean current density at −120mV
of mock-transfected neurons −10.4 ± 2.8 pA/pF) potential
contribution of the endogenous Ih current can be considered
minimal.
Discussion
Guided by the molecular model described in Saponaro et al.
(2018) and illustrated here in Fig. 1 A, we identified and
characterized the double mutation N547D/A548C in the
Table 2. Mean activation and deactivation time constants of HCN1 WT and NA/DC mutant in the presence and absence of TRIP8b (1a-4)
V/mV HCN1 WT HCN1 WT+ TRIP8b P value HCN1 NA/DC HCN1 NA/DC + TRIP8b P value
−70 τ activation (ms) 540.5 ± 71.3 875.7 ± 135.3 4.1E−03 477.2 ± 33.1 476.2 ± 42.8 1.0
−80 450.5 ± 74.4 721.1 ± 55.7 3.8E−03 386.6 ± 35.8 459.3 ± 46.7 0.4
−90 319.4 ± 46.3 516.4 ± 41.0 2.3E−03 299.6 ± 28.5 363.5 ± 34.2 0.25
−100 242.5 ± 28.9 364.0 ± 26.7 3.15E−03 238.8 ± 20.9 278.1 ± 21.0 0.3
−110 185.4 ± 18.4 305.6 ± 28.0 7.5E−03 201.4 ± 14.9 220.4 ± 13.0 0.4
−120 159.3 ± 13.2 257.6 ± 20.4 3.9E−03 177.9 ± 12.2 199.6 ± 21.6 0.4
−130 141.2 ± 11.4 221.9 ± 21.9 6.4E−04 153.5 ± 9.9 152.7 ± 11.2 1.0
−40 τ deactivation (ms) 117.7 ± 3.2 89.7 ± 6.2 7.7E−03 116.9 ± 8.7 120.8 ± 5.3 0.7
Data are reported as mean ± SEM. Statistical analysis performed with one-way ANOVA, followed by post-hoc Tukey test.
Figure 6. The NA/DC double mutation pre-
vents TRIP8b regulation of HCN1 gating in
cortical neurons from neonatal rats. (A)
Representative whole-cell current traces of hu-
man HCN1WT (top) and N478D/A479C (NA/DC)
mutant (bottom) recorded in primary cultures of
cortical neurons from neonatal rats transiently
expressing the channels alone (left) or with
TRIP8b (1a-4; right) and analyzed as described
in Materials and methods. (B) Top: Mean
current–voltage relationship of HCN1 WT (black
filled circle) and HCN1 WT + TRIP8b (1a-4; black
open circle). Bottom: Mean current–voltage re-
lationship of HCN1 NA/DC (red filled circle) and
HCN1 NA/DC + TRIP8b (1a-4; red open circle).
Empty triangles in both panels represent the
current recorded in the mock-transfected neu-
rons. Mean current density (pA/pF) measured at
−120mV of HCN1 WT = −57.5 ± 16.3 pA/pF;
HCN1 WT + TRIP8b (1a-4) = −132.4 ± 28 pA/pF;
HCN1 NA/DC = −36.3 ± 10.5 pA/pF; and HCN1
NA/DC + TRIP8b (1a-4) = −79 ± 11.5 pA/pF. The
values of the current recorded at −80, −90,
−110, −110, and −120 mV of both HCN1 WT and
mutant coexpressed with TRIP8b are signifi-
cantly higher of the current of HCN1 WT and
mutant alone. All values and exact P values are
reported in Table 3. (C) Mean normalized acti-
vation curves of HCN1 WT (black filled circle),
HCN1 WT + TRIP8b (1a-4; black open circle),
HCN1 NA/DC (red filled circle), and HCN1 NA/DC +
TRIP8b (1a-4; red open circle) channels obtained as
described in Materials and methods. (D)Mean half-
activation potential (V1/2) of HCN1 WT (black filled
circle) =−81.9 ± 1.4 mV; HCN1WT+ TRIP8b (1a-4; black open circle) =−88.6 ± 1.1 mV; HCN1 NA/DC (red filled circle) =−82.4 ± 1 mV; and HCN1 NA/DC+ TRIP8b (1a-4;
red open circle) = −82.2 ± 1.2 mV. P values are denoted within the scatterplot graph. The number of cells was ≥5. Statistical analysis performed with one-way ANOVA,
followed by post-hoc Fisher test.
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CNBD of human HCN2 channels (N478D/A479C in human
HCN1), which selectively impairs TRIP8b binding to CNBD
without affecting cAMP binding and regulation. The be-
havior of this double mutation has a dual implication: (1) it
functionally proves the allosteric model of TRIP8b versus
cAMP binding to the CNBD; and (2) it provides a tool for
in vivo studies of HCN channels that are fully sensitive to
cAMP, without any interference by the TRIP8b auxiliary
subunit.
Functional validation of the allosteric regulation of cAMP
binding to CNBD by TRIP8b
While the molecular pathway of cAMP potentiation of the HCN
channel current is well characterized (Wainger et al., 2001;
Table 3. Mean current density (pA/pF) of HCN1 WT and NA/DC mutant, in the presence and absence of TRIP8b (1a-4), from recordings obtained in
cortical neurons from neonatal rats
V/mV HCN1 WT HCN1 WT + TRIP8b P value HCN1 NA/DC HCN1 NA/DC + TRIP8b P value
−20 0.1 ± 0.3 0.1 ± 0.4 0.14 0.9 ± 1.0 0.7 ± 0.7 4.9E−02
−30 −1.1 ± 0.4 −1.4 ± 0.8 1.4E−03 −0.3 ± 0.6 −0.7 ± 0.6 3.7E−03
−40 −2.0 ± 0.5 −2.3 ± 1.1 2E−05 −0.9 ± 0.4 −1.5 ± 0.6 3.0E−03
−50 −3.3 ± 0.8 −3.3 ± 1.3 2E−04 −1.4 ± 0.4 −2.4 ± 0.9 5.2E−04
−60 −4.7 ± 1.2 −5.8 ± 2.1 6.4E−04 −2.0 ± 0.5 −4.4 ± 1.9 4.2E−05
−70 −6.7 ± 2.0 −10.6 ± 2.9 1.8E−03 −3.0 ± 1.1 −9.1 ± 4.8 4.8E−05
−80 −9.9 ± 2.9 −22.2 ± 5.2 2.3E−03 −6.8 ± 0.6 −18.7 ± 7.3 1.2E−05
−90 −14.1 ± 4.2 −36.2 ± 9.9 3.2E−03 −12.4 ± 5.5 −32.0 ± 9.6 1.7E−05
−100 −18.9 ± 5.5 −48.6 ± 13.7 3.7E−03 −16.3 ± 8.6 −42.2 ± 12.2 2.6E−05
−110 −24.0 ± 7.1 −59.8 ± 16.4 3.1E−03 −19.6 ± 10.5 −52.3 ± 15.6 2.1E−05
−120 −27.2 ± 7.7 −71.6 ± 19.6 6.2E−05 −22.5 ± 12.7 −62.4 ± 19.1 1.7E−05
Data are reported as mean ± SEM. Statistical analysis performed with one-way ANOVA, followed by post-hoc Fisher test.
Figure 7. The NA/DC double mutation prevents TRIP8b regulation of HCN1 gating in cortical neurons derived from hiPSCs. (A) Representative whole-
cell current traces of human HCN1 WT (top) and N478D/A479C (NA/DC) mutant (bottom) recorded in cortical neurons derived from hiPSCs transiently
expressing the channels alone (left) or with TRIP8b (1a-4; right) and analyzed as described in Materials and methods. (B)Mean current–voltage relationship of
HCN1 WT (black filled circle), HCN1 WT + TRIP8b (1a-4; black open circle), HCN1 NA/DC (red filled circle), and HCN1 NA/DC + TRIP8b (1a-4; red open circle).
The values of the current recorded at −80, −90, −110, −110, and −120 mV of both HCN1WT and mutant coexpressed with TRIP8b are significantly higher of the
current of HCN1WT andmutant alone. All values and exact P values are reported in Table 4. Mean current density (pA/pF) measured at −120mV of HCN1WT =
−27.2 ± 7.7 pA/pF; HCN1WT + TRIP8b (1a-4) = −71.5 ± 19.5 pA/pF; HCN1 NA/DC = −22.5 ± 12.7 pA/pF; and HCN1 NA/DC + TRIP8b (1a-4) = −62.4 ± 19 pA/pF. In
mock-transfected neurons, the current density at −120 mV was −12.5 ± 2 pA/pF, not reported in the graph for the sake of clarity. (C) Normalized mean
activation curves of HCN1WT + TRIP8b (1a-4; black open circle) and HCN1 NA/DC + TRIP8b (1a-4; red open circle) channels obtained as described in Materials
and methods. Data are presented as means ± SEM. The number of cells was ≥3. Statistical analysis was performed with one-way ANOVA, followed by post-hoc
Fisher test.
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Zagotta et al., 2003; Lolicato et al., 2011; Saponaro et al., 2014;
Weißgraeber et al., 2017; Gross et al., 2018; Porro et al., 2019), the
molecular mechanism of the antagonistic action of TRIP8b on
the cAMP effect is still debated.
Previously, we provided biochemical and structural evidence
indicating that TRIP8b interacts with two elements of the CNBD:
the N-bundle loop and the C-helix (Saponaro et al., 2014, 2018).
These findings fit well with the coexistence of both a direct
competition and an allosteric inhibition mechanism for the
TRIP8b regulation of cAMP binding to the CNBD. This complex
mechanism of regulation was previously postulated by us (Hu
et al., 2013; Saponaro et al., 2014, 2018) and others (Bankston
et al., 2017). Both regulators share the same binding sites on the
C-helix, which explains the direct competition model previously
supported by several studies (Han et al., 2011; DeBerg et al., 2015;
Bankston et al., 2017). On the other hand, the N-bundle loop,
which is part of the TRIP8b binding site on the CNBD but also
constitutes an allosteric regulative element for cAMP binding
(Saponaro et al., 2018), was postulated to be the molecular de-
terminant for allosteric inhibition.
The NA/DC double mutation is located in the N-bundle loop.
Functional testing of the NA/DC mutation in the context of the
full-length channel in living cells further confirms that TRIP8b
allosterically controls cAMP binding by interacting with the
N-bundle loop, since cAMP is still able to shift the channel ac-
tivation curve while the binding of TRP8b to the CNBD is im-
paired. These experiments represent an important validation for
the existence of an allosteric component in the regulation ex-
erted by TRIP8b on cAMP binding.
HCNNA/DC mutants as a tool for in vivo studies of HCN
channel regulation
Why is the HCN channel response to cAMP in the nervous
system limited by the interaction with TRIP8b? Because TRIP8b
is essential for the proper surface expression of HCN channels,
simply abolishing TRIP8b expression in vivo through genetic
deletion has not allowed such question to be addressed, as
knockout of TRIP8b results in drastically reduced HCN channel
currents and protein (Lewis et al., 2011). The observation that
the NA/DC mutation does not prevent the effects of TRIP8b on
channel expression and trafficking means that it may be em-
ployed as a genetic tool for dissecting the binary cAMP–TRIP8b
regulatory system of HCN channels in the brain. As the sensi-
tivity of neuronal HCN channels to cAMP is critical in several
physiological contexts (McCormick and Pape, 1990a, 1990b;
Wang et al., 2007; Heys et al., 2010; Marcelin et al., 2012), it
would be interesting to determine the consequences of an un-
abated response of HCN channels to cyclic nucleotides.
For instance, during development, the integrative properties
(resonance and temporal summation) of hippocampal CA1 py-
ramidal neurons display a dorsoventral gradient, which corre-
lates with changes of Ih current properties (Marcelin et al.,
2012). In particular, while Ih amplitude increases, its sensitiv-
ity to cAMP decreases symmetrically along the dorsoventral
axis. Strikingly, these variations match the dorsoventral profile
of expression of TRIP8b, and this may potentially explain such
variations. However, this tight correlation between hippocam-
pal Ih properties and HCN channels/TRIP8b coexpression has
not yet received a conclusive validation. As a consequence, a
crucial question concerning the binary TRIP8–cAMP regulation
of Ih in hippocampus has also not been addressed either: what is
the role of these two opposite gradients of Ih properties (am-
plitude versus cAMP sensitivity) in the proper development/
function of hippocampus? Genetic ablation of TRIP8b cannot
answer this question, as it will result in the dissolution of both
gradients. In this light, the NA/DC double mutant may represent
the resolutive genetic tool approach, as it will selectively impair
TRIP8b regulation of the cAMP effect without altering the am-
plitude gradient of hippocampal Ih.
The HCNNA/DC genetic tool may be similarly critical in un-
derstanding the development and function of other cortical
regions. Indeed, just like for CA1 pyramidal neurons, the inte-
grative properties of entorhinal cortex layer II stellate cells
show a dorsoventral profile of variation, which tightly correlates
Table 4. Mean current density (pA/pF) of HCN1 WT and NA/DC mutant, in the presence and absence of TRIP8b (1a-4), from recordings obtained in
cortical neurons derived from hiPSCs
V/mV HCN1 WT HCN1 WT + TRIP8b P value HCN1 NA/DC HCN1 NA/DC + TRIP8b P value
−20 3.8 ± 1.1 0.4 ± 1.7 0.5 1.4 ± 0.5 1.8 ± 0.9 0.9
−30 0.1 ± 0.8 −3.4 ± 2.2 1.9E−02 −0.5 ± 0.3 −1.2 ± 0.5 0.5
−40 −2.9 ± 1.1 −6.9 ± 3.2 0.1 −1.8 ± 0.5 −3.8 ± 0.6 8E−02
−50 −4.6 ± 1.5 −10.3 ± 4.2 8.6E−02 −3.2 ± 0.7 −6.0 ± 1.0 3.1E−02
−60 −6.8 ± 1.9 −14.0 ± 5.2 4.9E−02 −5.3 ± 1.0 −8.3 ± 1.4 3.4E−02
−70 −11.5 ± 2.7 −22.8 ± 6.2 3.9E−02 −8.6 ± 1.5 −12.3 ± 2.0 4.3E−02
−80 −20.5 ± 5.8 −38.4 ± 8.9 3.5E−02 −13.7 ± 3.1 −22.4 ± 3.5 3.1E−02
−90 −32.9 ± 9.7 −62.8 ± 13.5 2.0E−02 −19.5 ± 6.1 −38.1 ± 5.8 1.3E−02
−100 −43.4 ± 13.5 −88.5 ± 19.1 8.3E−03 −25.4 ± 8.7 −53.2 ± 7.6 7.2E−03
−110 −52.9 ± 17 −112 ± 23.9 4.0E−03 −30.5 ± 10.8 −66.7 ± 9.4 4.8E−03
−120 −57.5 ± 16.3 −132.4 ± 28 2.4E−03 −36.2 ± 10.5 −79.0 ± 11.6 3.0E−03
Data are reported as mean ± SEM. Statistical analysis was performed with one-way ANOVA, followed by post-hoc Fisher test.
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with changes in both amplitude and cAMP sensitivity of Ih (Heys
et al., 2010). It is thus plausible that Ih currents in several classes
of cortical principal cells may be fine-tuned by the binary
TRIP8–cAMP regulative system.
Given the fact that hippocampal and entorhinal neurons are
both part of the network controlling spatial learning, the NA/DC
genetic tool may become crucial in advancing the understanding
of Ih and cAMP signaling in the development of spatial memory
and navigation.
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Supplemental material
Figure S1. Biochemical characterization of HCN2 CNBD and TRIP8bnano proteins. (A) Representative SEC profiles of human HCN2 CNBD WT (black),
K666E (red), R650E (blue), and N547D/A548D (green) mutants. (B) Representative SEC profiles of TRIP8bnano WT (black) and D252N (orange) mutant. Both
CNBD and TRIP8bnano mutant proteins show a symmetrical and monodisperse peak comparable to their respective WT proteins, indicating that mutations did
not alter the biochemical features of the proteins. Peak fractions used for the ITC assay are delimited by the gray dotted lines. mAU, milli-arbitrary units.
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Figure S2. Structural insights into the N-bundle loop of the CNBD. Left: Ribbon representation of human HCN2 CNBD structure (cAMP-free conformation;
(Saponaro et al., 2014). The main structural elements are labeled, including β-roll; the N-terminal helical bundle, which is composed of α-helices E9 and A
(αE9 and αA) interconnected by the N-bundle loop (orange), the phosphate-binding cassette (PBC), and α-helix C. Right: Close-up view showing the residues of
the N-bundle loop, labeled in orange. The alignment of the N-bundle loop sequences of mammalian HCN and CNG channels (shown here is CNGA1) is reported
below. Nonconservative substitutions are highlighted in red.
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Figure S3. cAMP sensitivity of HCN2 NA/DC mutant channel. (A) Representative whole-cell current traces of mouse HCN2 WT (top) and N520D/A521C
(NA/DC) mutant (bottom) recorded in HEK 293T cells transiently expressing the channels with control solution (left) or with 1 µM cAMP (right) in the patch
pipette. Arrowheads indicate the current selected for analysis in B. (B) Normalized mean activation curves of HCN2 WT in control solution (blue filled circle)
and cAMP (blue open circle) and of HCN2 NA/DC in control solution (orange filled circle) and cAMP (orange open circle) obtained from tail currents collected
at −40 mV (see arrowheads in A). Lines show data fit to a Boltzmann function (see Materials and methods), from which we derived the half-activation
potentials (V1/2) plotted in C. (C)Mean half-activation potential (V1/2) of HCN2WT in control solution (blue filled circle) = −93.8 ± 0.9 mV; HCN2WTwith cAMP
(blue open circle) = −86.5 ± 0.7 mV; HCN2 NA/DC in control solution (orange filled circle) = −93 ± 0.4 mV; and HCN2 NA/DC with cAMP (orange open circle)
= −87.2 ± 0.7 mV. Data are plotted as dots, and the line represents the mean value ± SEM. The number of cells was ≥5. Statistical analysis performed with one-
way ANOVA, followed by post-hoc Tukey test (P values are denoted within the scatterplot graph).
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